Scarica l'app Stockscreener
13.30
4.32%
-0.60
Dopo l'orario di chiusura:
13.31
0.010
+0.08%
Precedente Chiudi:
$13.90
Aprire:
$14.045
Volume 24 ore:
1.39M
Relative Volume:
1.10
Capitalizzazione di mercato:
$1.29B
Reddito:
-
Utile/perdita netta:
$-137.25M
Rapporto P/E:
-7.037
EPS:
-1.89
Flusso di cassa netto:
$-121.97M
1 W Prestazione:
-5.54%
1M Prestazione:
+22.02%
6M Prestazione:
+183.58%
1 anno Prestazione:
+37.82%
Intervallo 1D:
$13.29
$14.17
Intervallo di 1 settimana:
$13.15
$14.17
Portata 52W:
$3.8951
$14.93
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
Nome
Oric Pharmaceuticals Inc
Settore
Industria
Telefono
(650) 388-5600
Indirizzo
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Confronta ORIC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
13.30 | 1.28B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Ripresa | Guggenheim | Buy |
| 2025-07-08 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-10-31 | Iniziato | Wells Fargo | Overweight |
| 2024-09-06 | Iniziato | Stifel | Buy |
| 2024-02-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-09-22 | Iniziato | Wedbush | Outperform |
| 2023-03-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-07-18 | Ripresa | Oppenheimer | Perform |
| 2022-04-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-03-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-22 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-03-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-07-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-01-25 | Downgrade | Citigroup | Buy → Neutral |
| 2020-08-13 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-03 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-19 | Iniziato | Citigroup | Neutral |
| 2020-05-19 | Iniziato | Guggenheim | Buy |
| 2020-05-19 | Iniziato | JP Morgan | Overweight |
| 2020-05-19 | Iniziato | Jefferies | Buy |
Mostra tutto
Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie
Can you recover from losses in ORIC Pharmaceuticals Inc.Quarterly Investment Review & Reliable Volume Spike Alerts - newser.com
What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackRisk Management & Consistent Profit Alerts - newser.com
ORIC Pharmaceuticals Inc. stock trend forecastJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
Developing predictive dashboards with ORIC Pharmaceuticals Inc. dataOil Prices & Capital Protection Trade Alerts - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
ORIC Pharmaceuticals Inc Stock Analysis and ForecastMarket Sentiment Surveys & Insights From Wall Street Professionals - earlytimes.in
Will breakout in ORIC Pharmaceuticals Inc. lead to full recoveryRate Hike & Low Drawdown Investment Strategies - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical toolsVolume Spike & Proven Capital Preservation Methods - newser.com
Oric Pharmaceuticals' (ORIC) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Historical volatility pattern of ORIC Pharmaceuticals Inc. visualized2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) CEO Jacob Chacko Sells 37,461 Shares - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CFO Sells $159,720.00 in Stock - MarketBeat
How robust is ORIC Pharmaceuticals Inc. (4TZ) stock financial position2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Oric Pharma CFO sells $159,718 in shares By Investing.com - Investing.com Canada
Visual analytics tools that track ORIC Pharmaceuticals Inc. performanceJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock today2025 Technical Overview & Safe Capital Growth Tips - newser.com
Insider Sell: Dominic Piscitelli Sells 11,000 Shares of ORIC Pha - GuruFocus
Oric Pharmaceuticals CEO Chacko Jacob sells $461k in stock By Investing.com - Investing.com Canada
Oric Pharmaceuticals stock hits 52-week high at 14.89 USD By Investing.com - Investing.com Nigeria
Oric Pharmaceuticals (NASDAQ:ORIC) Sets New 12-Month HighStill a Buy? - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) Trading Up 9.8%Here's What Happened - MarketBeat
What analysts say about ORIC Pharmaceuticals Inc stockGrowth Stock Opportunities & High Yield Trading Signals - earlytimes.in
How higher bond yields impact ORIC Pharmaceuticals Inc. (4TZ) stockJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Top chart patterns to watch in ORIC Pharmaceuticals Inc.Stop Loss & Fast Gaining Stock Strategy Reports - newser.com
Will ORIC Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Identifying reversal signals in ORIC Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com
How to use a screener to detect ORIC Pharmaceuticals Inc. breakouts2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Published on: 2025-10-05 04:16:39 - newser.com
We're Not Very Worried About ORIC Pharmaceuticals' (NASDAQ:ORIC) Cash Burn Rate - Yahoo Finance
Published on: 2025-10-03 04:25:32 - newser.com
Is ORIC Pharmaceuticals Inc. stock poised for growth2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Insider Selling: Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells 53,001 Shares of Stock - MarketBeat
Voya Investment Management LLC Reduces Position in Oric Pharmaceuticals, Inc. $ORIC - Defense World
ORIC Pharmaceuticals Inc 4TZ Stock Analysis and ForecastMarket Correction Analysis & Expert-Backed Recommendations That Deliver - earlytimes.in
Published on: 2025-09-29 09:52:14 - newser.com
Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Oric Pharmaceuticals Inc Azioni (ORIC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic | Chief Financial Officer |
Oct 06 '25 |
Sale |
14.52 |
11,000 |
159,719 |
48,317 |
| Chacko Jacob | PRESIDENT AND CEO |
Oct 06 '25 |
Sale |
12.32 |
37,461 |
461,520 |
531,419 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):